论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
10-羟基喜树碱抗肿瘤纳米给药系统研究进展
Authors Chen Y, Wang Z, Wang X, Su M, Xu F, Yang L, Jia L , Zhang Z
Received 2 June 2022
Accepted for publication 25 August 2022
Published 14 September 2022 Volume 2022:17 Pages 4227—4259
DOI https://doi.org/10.2147/IJN.S377149
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Yan Shen
Abstract: 10-Hydroxycamptothecin (HCPT) is a natural plant alkaloid from Camptotheca that shows potent antitumor activity by targeting intracellular topoisomerase I. However, factors such as instability of the lactone ring and insolubility in water have limited the clinical application of this drug. In recent years, unprecedented advances in biomedical nanotechnology have facilitated the development of nano drug delivery systems. It has been found that nanomedicine can significantly improve the stability and water solubility of HCPT. NanoMedicines with different diagnostic and therapeutic functions have been developed to significantly improve the anticancer effect of HCPT. In this paper, we collected reports on HCPT nanomedicines against tumors in the past decade. Based on current research advances, we dissected the current status and limitations of HCPT nanomedicines development and looked forward to future research directions.
Keywords: 10-hydroxycamptothecin, antitumor, nanomedicine, nano-drug delivery systems